ArticlePloS one2018
Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali.
Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 62 citations in OpenAlex.
- Factors Influencing Patient and System Delays in Women with Breast Cancer in Morocco: A Systematic Review.Asian Pacific journal of cancer prevention : APJCP · 2025Pooled it
- Health system factors that influence diagnostic and treatment intervals in women with breast cancer in sub-Saharan Africa: a systematic review.BMC public health · 2021Pooled it
- Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2021Pooled it
- Psychosocial influences on help-seeking behaviour for cancer in low-income and lower middle-income countries: a mixed-methods systematic review.BMJ global health · 2021Pooled it
- Effect of the SARS-CoV-2 pandemic on the opportunity to treat patients with breast cancer: experience at a reference cancer center in Mexico City.Cancer causes & control : CCC · 2026Observational
- First free microvascular deep inferior epigastric perforator (DIEP) flap for autologous breast reconstruction in Mali: a case report.International journal of surgery case reports · 2026Article
- Access and time to chemotherapy among Ethiopian cancer patients: a population-based registry study.The oncologist · 2026Article
- Depression and cancer outcomes in resource-limited settings: A cross-sectional analysis of treatment uptake and survival among metastatic breast cancer patients in Lagos, Nigeria.PLOS global public health · 2026Article
- Factors Contributing to Late Breast Cancer Diagnosis: A Qualitative Study on the Patient's Perspective in Tanzania.BMC women's health · 2025Article
- Late-Stage Diagnosis of Breast Cancer in Ghana: Needs for Patient and Public Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Article
- Anticipated First Contact and Time to Seek Healthcare for Possible Breast Cancer Symptoms: A Cross-Sectional Study in Rural Ghana.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review.BMJ open · 2025Article
- Exploring religious, spiritual, traditional, and folk healing practices for oncological disorders.BMC complementary medicine and therapies · 2025Article
- Differences in seeking breast cancer care between screening eligible versus ineligible Palestinian women.Scientific reports · 2025Article
- Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine.Biomedicines · 2025Review
- Characterization of intrinsic subtypes of breast cancer and their relationship with staging: an observational study.Frontiers in medicine · 2025Article
- Article
- Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.BMC women's health · 2024Article
- Article
- Factors associated with diagnostic and pre-treatment intervals among breast cancer patients attending care at the Uganda Cancer Institute: A cross-sectional study.Cancer medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyse patient and healthcare system related factors influencing the time to first healthcare visit, diagnosis and treatment of breast cancer patients in sub-Saharan Africa and the impact on survival in order to advise on early detection strategies.
methodsA prospective hospital cohort study was conducted at the only pathology department in Mali, at the University Hospital in Bamako. All the female patients with a breast cancer diagnosis between January and April 2016 were interviewed with a structured questionnaire (N = 64) to gather information about breast symptom recognition and first healthcare visit. Information on beginning of treatment and survival were collected at 18-months follow-up. Simple Cox regression analyses were performed.
resultsThe median time to first healthcare visit was 4.8 months, from first healthcare visit to diagnosis was 0.9 months and for the patients who started treatment (N = 46) the time from diagnosis to treatment was 1.3 months. Knowledge of breast-self-examination and correct symptom interpretation increased the chance of an earlier healthcare visit. Prolonged time to diagnosis was found with shorter duration to first healthcare visit, for working women compared to housewives and for those living within Bamako. Living outside Bamako and smaller tumour size (T1/T2) prolonged time to treatment. Visit of a traditional healer and larger tumour size (T3/T4) shortened survival time, whereas time to first healthcare visit and subsequent time to diagnosis had no influence on survival.
conclusionsDown-staging strategies are only useful if the continuum of breast cancer care is warranted for the majority of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.